Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,266 public trials 688 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Recruiting

Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors

NCT05687136

Conditions
Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, +5 more
Locations
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

NCT06311214

Conditions
Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Neoplasm Metastasis, +4 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Health System - Encinitas Encinitas, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 27 locations
View Trial Details
Recruiting

A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer

NCT04077099

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California Irvine Medical Center - Bldg 56, RT81, Rm 241 Orange, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center - McKinley Drive Tampa, Florida, United States
View all 40 locations
View Trial Details
Recruiting

(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors

NCT05208047

Conditions
Advanced Gastrointestinal Stromal Tumors, Digestive System Diseases, Digestive System Neoplasms, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • University of Arizona- Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
View all 126 locations
View Trial Details
Recruiting

FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers

NCT07638371

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +7 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

NCT05422911

Conditions
Castrate-sensitive, Castrate-sensitive Prostate Cancer, Genital Diseases, +15 more
Locations
  • VA Greater Los Angeles Healthcare System Los Angeles, California, United States
  • James A. Haley Veterans Administration Hospital Tampa, Florida, United States
  • VA Ann Arbor Healthcare System Ann Arbor, Michigan, United States
  • VA St. Louis Health Care System St Louis, Missouri, United States
View Trial Details

Related conditions